Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kei-Ching Yuen"'
Publikováno v:
HemaSphere, Vol 7, p e09566f7 (2023)
Externí odkaz:
https://doaj.org/article/41d60fdf73b146fb9071da0b2ab00789
Autor:
Rahman Ud Din, Anan Jiao, Yinxia Qiu, Aarmann Anil Mohinani Mohan, Kei-Ching Yuen, Hoi-Tung Wong, Timothy Ming-Hun Wan, Phoebe On-Yi Wong, Chun-Fung Sin
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 19, p 14646 (2023)
T lymphoblastic leukemia (T-ALL) is an aggressive haematolymphoid malignancy comprising 15% of acute lymphoblastic leukemia (ALL). Although its prognosis has improved with intensive chemotherapy, the relapse/refractory disease still carries a dismal
Externí odkaz:
https://doaj.org/article/3990d31a4026454b9b7e7c5a6429f551
Publikováno v:
Blood. 140:11554-11556
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb9da612950ec86e50784ce9fe4d6b15
https://doi.org/10.1182/blood-2022-165941
https://doi.org/10.1182/blood-2022-165941
Publikováno v:
Cancer Research. 83:6199-6199
Acute lymphoblastic leukemia (ALL) is an aggressive hematolymphoid malignancy and the prognosis is poor in adults with long-term survival of only 30% due to the high prevalence of high-risk subtypes. Therefore, there is an urgent need to develop nove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cb41b42a4e1a2747e8b611c9d9f8073
https://doi.org/10.1158/1538-7445.am2023-6199
https://doi.org/10.1158/1538-7445.am2023-6199
Publikováno v:
Cancer Research. 83:1574-1574
Acute lymphoblastic leukaemia (ALL) is an aggressive and highly lethal malignancy caused by clonal mutations in lymphoid progenitor cells. The prognosis for adult ALL remains poor, with only 30-40% of adult patients achieving long-term remission. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba1f4c5ec640e053db3f682c2a5d404d
https://doi.org/10.1158/1538-7445.am2023-1574
https://doi.org/10.1158/1538-7445.am2023-1574